BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21704103)

  • 1. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants.
    Verhaegh SJ; de Vogel CP; Riesbeck K; Lafontaine ER; Murphy TF; Verbrugh HA; Jaddoe VW; Hofman A; Moll HA; van Belkum A; Hays JP
    Vaccine; 2011 Aug; 29(34):5603-10. PubMed ID: 21704103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children.
    Meier PS; Freiburghaus S; Martin A; Heiniger N; Troller R; Aebi C
    Pediatr Infect Dis J; 2003 Mar; 22(3):256-62. PubMed ID: 12634588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.
    Tan TT; Christensen JJ; Dziegiel MH; Forsgren A; Riesbeck K
    Infect Immun; 2006 Nov; 74(11):6377-86. PubMed ID: 16966403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane proteins of Moraxella catarrhalis.
    Carson RT; McDonald DF; Kehoe MA; Calvert JE
    Immunology; 1994 Sep; 83(1):107-13. PubMed ID: 7529743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to surface protein A of Streptococcus pneumoniae and to high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media.
    Samukawa T; Yamanaka N; Hollingshead S; Murphy TF; Faden H
    J Infect Dis; 2000 May; 181(5):1842-5. PubMed ID: 10823798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.
    Verhaegh SJ; Stol K; de Vogel CP; Riesbeck K; Lafontaine ER; Murphy TF; van Belkum A; Hermans PW; Hays JP
    Clin Vaccine Immunol; 2012 Jun; 19(6):914-8. PubMed ID: 22539468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.
    Ren D; Almudevar AL; Murphy TF; Lafontaine ER; Campagnari AA; Luke-Marshall N; Casey JR; Pichichero ME
    Vaccine; 2015 Oct; 33(43):5809-5814. PubMed ID: 26392013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.
    Chen D; Barniak V; VanDerMeid KR; McMichael JC
    Infect Immun; 1999 Mar; 67(3):1310-6. PubMed ID: 10024576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antibodies by Staphylococcus aureus nasal colonization in young children.
    Verkaik NJ; Lebon A; de Vogel CP; Hooijkaas H; Verbrugh HA; Jaddoe VW; Hofman A; Moll HA; van Belkum A; van Wamel WJ
    Clin Microbiol Infect; 2010 Aug; 16(8):1312-7. PubMed ID: 19832714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human antibody response to Moraxella catarrhalis antigens.
    Gabre-Selasie S
    East Afr Med J; 1998 Mar; 75(3):175-9. PubMed ID: 9640818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.
    Murphy TF; Brauer AL; Aebi C; Sethi S
    Infect Immun; 2005 Dec; 73(12):8161-6. PubMed ID: 16299311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development.
    Riesbeck K; Tan TT; Forsgren A
    Acta Biochim Pol; 2006; 53(3):445-56. PubMed ID: 16964325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.
    Murphy TF; Brauer AL; Aebi C; Sethi S
    Infect Immun; 2005 Jun; 73(6):3471-8. PubMed ID: 15908376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease.
    Adlowitz DG; Kirkham C; Sethi S; Murphy TF
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):139-46. PubMed ID: 16420607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities.
    Pearson MM; Lafontaine ER; Wagner NJ; St Geme JW; Hansen EJ
    Infect Immun; 2002 Aug; 70(8):4523-33. PubMed ID: 12117964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children.
    Meier PS; Troller R; Grivea IN; Syrogiannopoulos GA; Aebi C
    Vaccine; 2002 Mar; 20(13-14):1754-60. PubMed ID: 11906762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2.
    Nordström T; Blom AM; Forsgren A; Riesbeck K
    J Immunol; 2004 Oct; 173(7):4598-606. PubMed ID: 15383594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response against mycobacterial antigens in children with tuberculosis.
    Demkow U; Ziołkowski J; Białas-Chromiec B; Filewska M; Zielonka T; Wasik M; Rowińska-Zakrzewska E
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():63-73. PubMed ID: 17072031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection.
    Christensen JJ; Renneberg J; Bruun B; Forsgren A
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):14-7. PubMed ID: 7719906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.